Rockefeller Capital Management’s AtriCure ATRC Stock Holding History
Bought
Maintained
Sold
Other funds holding ATRC
HRCM
NAMI
Rockefeller Capital Management's ATRC Position: Q2 2026 in Review
Rockefeller Capital Management reduced its AtriCure (ATRC) stake by 29% in Q2 2026, selling an estimated $39.5K and leaving 3,506 shares worth $98.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3003.
Rockefeller Capital Management first reported a position in ATRC in Q3 2019 and has held it in 20 quarters since. The position peaked at $335K in Q1 2023. 251 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.
- Rockefeller Capital Management held 3,506 shares of AtriCure worth $98.1K as of Q2 2026.
- Rockefeller Capital Management sold 1,405 AtriCure shares in Q2 2026, an estimated $39.5K.
- AtriCure made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #3003 holding.
- Rockefeller Capital Management first reported a position in AtriCure in Q3 2019 and has held it in 20 quarters since.
- Rockefeller Capital Management's AtriCure position peaked at $335K in Q1 2023.
- 251 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.
Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.